Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients

Rectal cancer constitutes approximately one-third of all colorectal cancers and contributes to considerable mortality globally. In contrast to colon cancer, the standard treatment for localized rectal cancer often involves neoadjuvant chemoradiotherapy. Tumour response rates to treatment show substa...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkan, Aylin, Hofving, Tobias, Angenete, Eva, Yrlid, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317379/
https://www.ncbi.nlm.nih.gov/pubmed/34321074
http://dx.doi.org/10.1186/s40364-021-00313-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317379/
https://www.ncbi.nlm.nih.gov/pubmed/34321074
http://dx.doi.org/10.1186/s40364-021-00313-9

Ejemplares similares